Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.9B | 1.9B | 1.7B | 1.7B |
Cost of revenue | — | 414M | 362M | — |
Gross profit | — | 1.5B | 1.4B | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 690M | 674M | — |
Other operating expenses | 1.1B | 80M | 71M | 1.1B |
Operating income | 563M | 517M | 415M | 415M |
Non operating interest income | ||||
Income | — | 22M | 26M | 2M |
Expense | 30M | 50M | 47M | 36M |
Other income expense | — | 261M | -30M | — |
Pretax income | 523M | 747M | 362M | 381M |
Tax provision | 92M | 135M | 77M | -402M |
Net income | 434M | 587M | 301M | 841M |
Basic EPS | 1.0 | 1.3 | 0.7 | 1.9 |
Diluted EPS | 1.0 | 1.3 | 0.7 | 1.9 |
Basic average shares | 450.3M | 450.1M | 449.9M | 450.4M |
Diluted average shares | 450.8M | 450.6M | 450.5M | 450.9M |
EBITDA | 779M | 744M | 641M | 623M |
Net income from continuing op. | 425M | 607M | 277M | 844M |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | — | — | — | — |